Hepatoerythropoietic Porphyria
|
0.500 |
GermlineCausalMutation
|
disease |
ORPHANET |
Excretion of porphyrins and residual UROD activity in erythrocytes were measured and compared with those of other patients with HEP.
|
21668429 |
2011 |
Hepatoerythropoietic Porphyria
|
0.500 |
GermlineCausalMutation
|
disease |
ORPHANET |
Two novel uroporphyrinogen decarboxylase (URO-D) mutations causing hepatoerythropoietic porphyria (HEP).
|
17240319 |
2007 |
Porphyria Cutanea Tarda
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Hepatoerythropoietic Porphyria
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Familial porphyria cutanea tarda
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies.
|
19233912 |
2009 |
Familial porphyria cutanea tarda
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Familial porphyria cutanea tarda in Spain: characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation.
|
23545314 |
2013 |
Porphyria Cutanea Tarda, Type I
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Erythrocyte uroporphyrinogen decarboxylase activity in 80 unrelated patients with porphyria cutanea tarda.
|
1610684 |
1992 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
UROD activity has a high diagnostic accuracy for differentiating the 2 PCT types, and a model that takes into account both clinical information and laboratory test results can be used to predict fPCT.
|
19233912 |
2009 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Porphyria cutanea tarda (PCT) is a skin disease that results from decreased activity of uroporphyrinogen decarboxylase (UROD).
|
9516680 |
1998 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Porphyria cutanea tarda in human beings is believed to be due to reduced hepatic uroporphyrinogen decarboxylase activity.
|
1359994 |
1992 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Uroporphyrinogen decarboxylase activity was measured in hemoglobin-free lysates from two patients with hepatoerythropoietic porphyria (HEP) and from 12 unrelated patients with familial porphyria cutanea tarda (PCT).
|
6375356 |
1984 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Forty-four patients (37%) had decreased UROD activity and were classified as familial-PCT.
|
12699242 |
2002 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Patients with porphyria cutanea tarda (PCT) have a susceptibility to reversible inactivation of hepatocyte uroporphyrinogen decarboxylase, which can be triggered by alcohol, hepatitis C virus, and other agents.
|
11499833 |
2001 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Mild to moderate iron overload is common in PCT, as iron is one of the factors which trigger the clinical manifestations of the disease through the inactivation of URO-D. A role for genetic hemochromatosis in the development of iron overload in sporadic PCT has been hypothesized in the past.
|
9425935 |
1998 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Porphyria cutanea tarda (PCT) results from a decreased activity of uroporphyrinogen decarboxylase, the fifth enzyme in heme biosynthesis.
|
15186324 |
2004 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
With the erythrocyte assay, multiple examples of decreased uroporphyrinogen decarboxylase activity were detected in members of three families of patients with porphyria cutanea tarda.
|
993332 |
1976 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Porphyria cutanea tarda (PCT) results from decreased activity of uroporphyrinogen decarboxylase (UROD) in the liver.
|
23545314 |
2013 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Besides the epidemiological relevance of the association between PCT and hemochromatosis, however, it remains to be fully understood how iron overload, and in particular the cellular modifications of the iron status secondary to hemochromatosis mutations, affect the activity of URO-D, and how the altered iron metabolism interacts with the other two common triggers for PCT and etiological agents for the associated liver disease: alcohol and hepatitis viruses.
|
10189391 |
1999 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
The aim of the present work was to establish the relative frequencies of the symptomatic and hereditary forms by the determination of the URO-D enzyme in the PCT patients who were regularly treated at the Centre for Porphyrins in our Institute.
|
1358034 |
1992 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Porphyria cutanea tarda (PCT) is associated in most cases with iron overload, which may participate in decreased activity of uroporphyrinogen decarboxylase in the liver.
|
11260010 |
2001 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Porphyria cutanea tarda (PCT) results from decreased activity of hepatic uroporphyrinogen decarboxylase (UROD).
|
20163457 |
2010 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Porphyria cutanea tarda (PCT) is the only porphyria that has both genetic and/or environmental factors that lead to reduced activity of uroporphyrinogen decarboxylase in the liver.
|
31326287 |
2019 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
After identifying the porphyria cutanea tarda by urine analysis we found that the serum activity of uroporphyrinogen decarboxylase (UROD) was normal, meaning a partial inactivation of UROD in liver tissue due to external factors.
|
16990695 |
2006 |
Porphyria Cutanea Tarda
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Two patients with excessive excretion of uroporphyrins or characteristic chromatograms, or both, and decreased uroporphyrinogen decarboxylase activity were classified as having subclinical porphyria cutanea tarda, and two with decreased uroporphyrinogen decarboxylase activity only were classified as having latent porphyria cutanea tarda.
|
622106 |
1978 |